These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial. Lambert MNT, Thybo CB, Lykkeboe S, Rasmussen LM, Frette X, Christensen LP, Jeppesen PB. Am J Clin Nutr; 2017 Sep; 106(3):909-920. PubMed ID: 28768651 [Abstract] [Full Text] [Related]
4. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R. PLoS Med; 2008 Oct 14; 5(10):e196. PubMed ID: 18922041 [Abstract] [Full Text] [Related]
6. Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial. Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E. Clin Ther; 2007 Sep 14; 29(9):1937-49. PubMed ID: 18035193 [Abstract] [Full Text] [Related]
8. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial. Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K. Chin Med J (Engl); 2004 Jul 14; 117(7):1029-35. PubMed ID: 15265377 [Abstract] [Full Text] [Related]
9. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. Zhang G, Qin L, Shi Y. J Bone Miner Res; 2007 Jul 14; 22(7):1072-9. PubMed ID: 17419678 [Abstract] [Full Text] [Related]
10. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial. Rønn SH, Harsløf T, Oei L, Pedersen SB, Langdahl BL. Osteoporos Int; 2021 Jan 14; 32(1):185-191. PubMed ID: 33030563 [Abstract] [Full Text] [Related]
11. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Jolly EE, Bjarnason NH, Neven P, Plouffe L, Johnston CC, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW. Menopause; 2003 Jan 14; 10(4):337-44. PubMed ID: 12851517 [Abstract] [Full Text] [Related]
12. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis. Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L. Menopause; 2013 Jan 14; 20(1):72-8. PubMed ID: 22968256 [Abstract] [Full Text] [Related]
13. Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women. Delmas PD, Davis SR, Hensen J, Adami S, van Os S, Nijland EA. Osteoporos Int; 2008 Aug 14; 19(8):1153-60. PubMed ID: 18256777 [Abstract] [Full Text] [Related]
15. Alpha-ketoglutarate decreases serum levels of C-terminal cross-linking telopeptide of type I collagen (CTX) in postmenopausal women with osteopenia: six-month study. Filip RS, Pierzynowski SG, Lindegard B, Wernerman J, Haratym-Maj A, Podgurniak M. Int J Vitam Nutr Res; 2007 Mar 14; 77(2):89-97. PubMed ID: 17896582 [Abstract] [Full Text] [Related]
16. [A randomised clinical trial to study the effects of raloxifene hydrochloride on bone mineral density, biochemical markers of bone metabolism and serum lipids in postmenopausal women]. Zheng SR, Wu YY, Zhang ZL, Yang X, Hui Y, Zhang Y, Chen SL, Den WH, Liu H, Ekangaki A, Stocks J, Harper K, Liu JL. Zhonghua Fu Chan Ke Za Zhi; 2003 Apr 14; 38(4):226-9. PubMed ID: 12885371 [Abstract] [Full Text] [Related]
17. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. Holloway L, Kohlmeier L, Kent K, Marcus R. J Clin Endocrinol Metab; 1997 Apr 14; 82(4):1111-7. PubMed ID: 9100582 [Abstract] [Full Text] [Related]
18. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L. J Bone Miner Res; 2004 May 14; 19(5):737-44. PubMed ID: 15068496 [Abstract] [Full Text] [Related]
19. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis]. Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harpe K. Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):269-73. PubMed ID: 15059505 [Abstract] [Full Text] [Related]
20. Stereological study of the effect of black olive hydroalcoholic extract on osteoporosis in vertebra and tibia in ovariectomized rats. Noorafshan A, Dabbaghmanesh MH, Tanideh N, Koohpeyma F, Rasooli R, Hajihoseini M, Bakhshayeshkaram M, Hosseinabadi OK. Osteoporos Int; 2015 Sep 17; 26(9):2299-307. PubMed ID: 26174878 [Abstract] [Full Text] [Related] Page: [Next] [New Search]